Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pileri

Showing results (241-250 of 524) with videos related to

Pageof 53
Sort By:
Stem Cells (Dayton, Ohio)|April 24, 1999
Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patientsC Tarella, F Zallio, D Caracciolo, et al.
British Journal of Haematology|July 1, 1995
CD3-induced T-cell activation in the bone marrow of myeloma patients: major role of CD4+ cellsA Bianchi, L Montacchini, P Barral, et al.
Bone Marrow Transplantation|January 1, 1997
Multicyclic, dose-intensive chemotherapy supported by hemopoietic progenitors in refractory myeloma patientsA Palumbo, A Pileri, S Triolo, et al.
European Journal of Haematology|October 1, 1989
Platelet behavior in essential thrombocythemia: a study of 31 casesM Bazzan, G Tamponi, P Schinco, et al.
Blood|September 10, 1998
The Italian experience on interferon as maintenance treatment in multiple myeloma: ten years afterA Pulsoni, G Avvisati, M T Petrucci, et al.
Bone Marrow Transplantation|January 10, 2001
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograftC Tarella, D Caracciolo, P Gavarotti, et al.
Blood|June 15, 1995
Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patientsM Massaia, P Borrione, C Attisano, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 15, 2012
Combination treatment in CTCL: the current role of bexaroteneC Delfino, V Grandi, A Pileri, et al.
Histopathology|February 22, 2005
Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for HaematopathologyL Leoncini, G Delsol, R D Gascoyne, et al.
Journal of Clinical Pathology|September 5, 2006
Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phaseEllen C Obermann, Philip Went, Alexandar Tzankov, et al.
Pageof 53

Showing results (241-250 of 524) with videos related to

Sort By:
Pageof 53
Stem Cells (Dayton, Ohio)|April 24, 1999
Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patientsC Tarella, F Zallio, D Caracciolo, et al.
British Journal of Haematology|July 1, 1995
CD3-induced T-cell activation in the bone marrow of myeloma patients: major role of CD4+ cellsA Bianchi, L Montacchini, P Barral, et al.
Bone Marrow Transplantation|January 1, 1997
Multicyclic, dose-intensive chemotherapy supported by hemopoietic progenitors in refractory myeloma patientsA Palumbo, A Pileri, S Triolo, et al.
European Journal of Haematology|October 1, 1989
Platelet behavior in essential thrombocythemia: a study of 31 casesM Bazzan, G Tamponi, P Schinco, et al.
Blood|September 10, 1998
The Italian experience on interferon as maintenance treatment in multiple myeloma: ten years afterA Pulsoni, G Avvisati, M T Petrucci, et al.
Bone Marrow Transplantation|January 10, 2001
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograftC Tarella, D Caracciolo, P Gavarotti, et al.
Blood|June 15, 1995
Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patientsM Massaia, P Borrione, C Attisano, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 15, 2012
Combination treatment in CTCL: the current role of bexaroteneC Delfino, V Grandi, A Pileri, et al.
Histopathology|February 22, 2005
Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for HaematopathologyL Leoncini, G Delsol, R D Gascoyne, et al.
Journal of Clinical Pathology|September 5, 2006
Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phaseEllen C Obermann, Philip Went, Alexandar Tzankov, et al.
Pageof 53